-
Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.
-
Eletriptan is the newest triptan to be approved for the treatment of migraine headaches. It marks the seventh entry into this crowded market.
-
Use of Hip Protectors in Nursing Homes: Cluster Randomized Controlled Trial; Disclosing Unanticipated Outcomes and Medical Errors; Non-Invasive Positive Pressure Ventilation to Treat Respiratory Failure Resulting from Exacerbations of COPD
-
-
The Bush administration may have failed in two attempts to offer a prescription drug discount plan, but that wont stop it from trying again.
-
The final security standards and transaction modifications for electronic health information are here at last.
-
Pharmacists are experts at dispensing the correct drug in the correct dosage to the correct patient. Two pharmacists, however, suggest that the profession can do a better job of considering the public, collectively, as a patient.
-
A study of long-term, low-dose warfarin (Coumadin) in the prevention of blood-clotting disorders showed such promise that the National Institutes of Health, the trials sponsor, stopped the study early.
-
HHS proposes smallpox vaccination compensation; Counterfeit epoetin alfa presents hazard to patients; Adverse events associated with sirolimus (Rapamune); FDA proposes standards for dietary supplements; APhA releases patient, pharmacist publications.
-
The FDA has approved pyridostigmine bromide to increase survival after Soman nerve gas poisoning, which causes loss of muscle control and death from respiratory failure. The product is approved for combat use by United States military personnel.
